Hematology · 2 h ago
Review compares human cell models for inherited platelet disorders
A review in Haematologica examines human cell-based models used to study inherited platelet disorders and evaluate uncertain genetic variants. It compares primary-cell, induced-pluripotent-stem-cell, immortalized-cell, and emerging organoid approaches, highlighting trade-offs in biological relevance, scalability, and platelet production.
- Primary-cell models offer relevance but vary between donors.
- iPSC models face platelet-production and characterization challenges.
- No single model suits every research question.
- Validation against patient material remains important.
Inherited platelet disorders affect platelet number, function, or both. This review describes human cell-based models for investigating disease mechanisms and establishing whether genetic variants of uncertain significance cause disease. It notes that scarcity of bone-marrow megakaryocytes and limitations of murine models have driven the development of human systems.
Primary hematopoietic stem-cell-derived megakaryocytes offer high biological relevance for patient-specific modeling, but require donor material and show inter-donor variability. Induced pluripotent stem cells provide a renewable source, although efficient platelet production and functional characterization remain challenging. Leukemia-derived cell lines are genetically tractable but do not fully reproduce physiological thrombopoiesis. The review also discusses an immortalized megakaryocyte line as a scalable platform for maturation, platelet production, and selected function assays, as well as emerging three-dimensional and organoid systems.
The authors emphasize that no model is optimal for every research question and that findings should be validated against primary patient material. These platforms support research into disease mechanisms, variant validation, and preclinical therapy evaluation; the review does not report a clinical trial or establish changes to patient care.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Haematologica: Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.